AAAAAA

   
Results: 1-25 | 26-37
Results: 1-25/37
A RANDOMIZED TRIAL OF HIGH-DOSE POLYVALENT INTRAVENOUS IMMUNOGLOBULIN(HDIGG) VS. CYTOMEGALOVIRUS (CMV) HYPERIMMUNE IGG IN ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTS (HSCT)
Authors: ZIKOS P VANLINT MT LAMPARELLI T GUALANDI F OCCHINI D MORDINI N BERISSO C BREGANTE S BACIGALUPO A
Citation: P. Zikos et al., A RANDOMIZED TRIAL OF HIGH-DOSE POLYVALENT INTRAVENOUS IMMUNOGLOBULIN(HDIGG) VS. CYTOMEGALOVIRUS (CMV) HYPERIMMUNE IGG IN ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTS (HSCT), Haematologica, 83(2), 1998, pp. 132-137
ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOR PATIENTS WITH HIGH-RISK ACUTE LYMPHOBLASTIC-LEUKEMIA - FAVORABLE IMPACT OF CHRONIC GRAFT-VERSUS-HOST DISEASE ON SURVIVAL AND RELAPSE
Authors: ZIKOS P VANLINT MT LAMPARELLI T GUALANDI F OCCHINI D BREGANTE S BERISSO G MORDINI N INCAGLIATO M FUGAZZA G SESSAREGO M BACIGALUPO A
Citation: P. Zikos et al., ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOR PATIENTS WITH HIGH-RISK ACUTE LYMPHOBLASTIC-LEUKEMIA - FAVORABLE IMPACT OF CHRONIC GRAFT-VERSUS-HOST DISEASE ON SURVIVAL AND RELAPSE, Haematologica, 83(10), 1998, pp. 896-903
EARLY PREDICTORS OF TRANSPLANT-RELATED MORTALITY (TRM) AFTER ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTS (HSCT) - BLOOD UREA NITROGEN AND BILIRUBIN
Authors: BACIGALUPO A VANLINT BM LAMPARELLI T GUALANDI F OCCHINI D MORDINI N BERISSO G BREGANTE S ZIKOS P LOMBARDI A
Citation: A. Bacigalupo et al., EARLY PREDICTORS OF TRANSPLANT-RELATED MORTALITY (TRM) AFTER ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTS (HSCT) - BLOOD UREA NITROGEN AND BILIRUBIN, Experimental hematology, 26(8), 1998, pp. 368-368
ALLOGENEIC BONE-MARROW OR PERIPHERAL-BLOOD CELL TRANSPLANTS IN ADULTSWITH HEMATOLOGIC MALIGNANCIES - A SINGLE-CENTER EXPERIENCE
Authors: BACIGALUPO A ZIKOS P VANLINT MT VALBONESI M LAMPARELLI T GUALANDI F OCCHINI D MORDINI N BREGANTE S BERISSO G VITALE V SESSAREGO M MARMONT AM
Citation: A. Bacigalupo et al., ALLOGENEIC BONE-MARROW OR PERIPHERAL-BLOOD CELL TRANSPLANTS IN ADULTSWITH HEMATOLOGIC MALIGNANCIES - A SINGLE-CENTER EXPERIENCE, Experimental hematology, 26(5), 1998, pp. 409-414
FAILURE OF AUTOLOGOUS STEM-CELL TRANSPLANTATION IN REFRACTORY THROMBOCYTOPENIC PURPURA
Authors: MARMONT AM VANLINT MT OCCHINI D LAMPARELLI T BACIGALUPO A
Citation: Am. Marmont et al., FAILURE OF AUTOLOGOUS STEM-CELL TRANSPLANTATION IN REFRACTORY THROMBOCYTOPENIC PURPURA, Bone marrow transplantation, 22(8), 1998, pp. 827-828
FOSCARNET VS GANCICLOVIR FOR CYTOMEGALOVIRUS (CMV) ANTIGENEMIA AFTER ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTATION (HSCT) - A RANDOMIZED STUDY
Authors: MORETTI S ZIKOS P VANLINT MT TEDONE E OCCHINI D GUALANDI F LAMPARELLI T MORDINI N BERISSO G BREGANTE S BRUNO B BACIGALUPO A
Citation: S. Moretti et al., FOSCARNET VS GANCICLOVIR FOR CYTOMEGALOVIRUS (CMV) ANTIGENEMIA AFTER ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTATION (HSCT) - A RANDOMIZED STUDY, Bone marrow transplantation, 22(2), 1998, pp. 175-180
LOW TRANSPLANT MORTALITY IN ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) FOR ACUTE MYELOID-LEUKEMIA - A RANDOMIZED STUDY OF LOW-DOSE CYCLOSPORINE VS LOW-DOSE CYCLOSPORINE AND LOW-DOSE METHOTREXATE
Authors: ZIKOS P VANLINT MT FRASSONI F LAMPARELLI T GUALANDI F OCCHINI D MORDINI N BERISSO G BREGANTE S BACIGALUPO A
Citation: P. Zikos et al., LOW TRANSPLANT MORTALITY IN ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) FOR ACUTE MYELOID-LEUKEMIA - A RANDOMIZED STUDY OF LOW-DOSE CYCLOSPORINE VS LOW-DOSE CYCLOSPORINE AND LOW-DOSE METHOTREXATE, Bone marrow transplantation, 21, 1998, pp. 38-38
ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTATION (HSCT) FOR PATIENTS WITH HIGH-RISK ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - FAVORABLE IMPACTOF CHRONIC GRAFT-VERSUS-HOST DISEASE (CGVHD) ON SURVIVAL AND RELAPSE
Authors: ZIKOS PM VANLINT MT LAMPARELLI T GUALANDI F OCCHINI D BREGANTE S BERISSO G MORDINI N INCAGLIATO M FUGAZZA G SESSAREGO M VITALE V BARRA S CORVO R BACIGALUPO A
Citation: Pm. Zikos et al., ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTATION (HSCT) FOR PATIENTS WITH HIGH-RISK ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - FAVORABLE IMPACTOF CHRONIC GRAFT-VERSUS-HOST DISEASE (CGVHD) ON SURVIVAL AND RELAPSE, Bone marrow transplantation, 21, 1998, pp. 39-39
ALLOGENEIC BONE-MARROW OR PERIPHERAL-BLOOD CELL TRANSPLANTS IN ADULTSWITH HEMATOLOGIC MALIGNANCIES - A SINGLE-CENTER EXPERIENCE
Authors: BACIGALUPO A ZIKOS P VANLINT MT VALBONESI M LAMPARELLI T GUALANDI F OCCHINI D MORDINI N BREGANTE S BERISSO G VITALE V SESSAREGO M MARMONT AM
Citation: A. Bacigalupo et al., ALLOGENEIC BONE-MARROW OR PERIPHERAL-BLOOD CELL TRANSPLANTS IN ADULTSWITH HEMATOLOGIC MALIGNANCIES - A SINGLE-CENTER EXPERIENCE, Bone marrow transplantation, 21, 1998, pp. 40-40
UNRELATED DONOR BMT FOR CML
Authors: DINI G LAMPARELLI T RONDELLI R BARBANTI M GARBARINO L LANINO E GUIDI S ROSTI G ALESSANDRINO EP LOCATELLI F MARENCO P SOLIGO D DIBARTOLOMEO P AVERSA F LANASA G BUSCA A MAJOLINO I DELAURENZI A BACIGALUPO A
Citation: G. Dini et al., UNRELATED DONOR BMT FOR CML, Bone marrow transplantation, 21, 1998, pp. 112-112
UNMANIPULATED TRANSPLANTS FROM 1-2-ANTIGEN MISMATCHED FAMILY DONORS
Authors: BACIGALUPO A VANLINT MT LAMPARELLI T GUALANDI F OCCHINI D MORDINI N BERISSO G BREGANTE S LOMBARDI A ZIKOS P
Citation: A. Bacigalupo et al., UNMANIPULATED TRANSPLANTS FROM 1-2-ANTIGEN MISMATCHED FAMILY DONORS, Bone marrow transplantation, 21, 1998, pp. 121-121
THIOTEPA CYCLOPHOSPHAMIDE (THIO-CY) AS CONDITIONING REGIMEN FOR ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTS (HSCT) - REDUCING THE DOSE FOR PATIENTS AGED 45 TO 60 YEARS
Authors: BACIGALUPO A VANLINT MT LAMPARELLI T GUALANDI F OCCHINI D MORDINI N BERISSO G BREGANTE S LOMBARDI A ZIKOS P
Citation: A. Bacigalupo et al., THIOTEPA CYCLOPHOSPHAMIDE (THIO-CY) AS CONDITIONING REGIMEN FOR ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTS (HSCT) - REDUCING THE DOSE FOR PATIENTS AGED 45 TO 60 YEARS, Bone marrow transplantation, 21, 1998, pp. 357-357
A RANDOMIZED TRIAL OF HIGH-DOSE POLYVALENT INTRAVENOUS IMMUNOGLOBULIN(HDIGG) VS. CYTOMEGALOVIRUS (CMV) HYPERIMMUNE IGG IN ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTS (HSCT)
Authors: ZIKOS P VANLINT MT LAMPARELLI T GUALANDI F OCCHINI D MORDINI N BERISSO G BREGANTE S BACIGALUPO A
Citation: P. Zikos et al., A RANDOMIZED TRIAL OF HIGH-DOSE POLYVALENT INTRAVENOUS IMMUNOGLOBULIN(HDIGG) VS. CYTOMEGALOVIRUS (CMV) HYPERIMMUNE IGG IN ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTS (HSCT), Bone marrow transplantation, 21, 1998, pp. 490-490
UNRELATED DONOR MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA
Authors: DINI G LAMPARELLI T RONDELLI R LANINO E BARBANTI M COSTA C MANFREDINI L GUIDI S ROSTI G ALESSANDRINO EP LOCATELLI F MARENCO P SOLIGO D DIBARTOLOMEO P AVERSA F LANASA G BUSCA A MAJOLINO I DELAURENZI A BACIGALUPO A
Citation: G. Dini et al., UNRELATED DONOR MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA, British Journal of Haematology, 102(2), 1998, pp. 544-552
LOW TRANSPLANT MORTALITY IN ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOID-LEUKEMIA - A RANDOMIZED STUDY OF LOW-DOSE CYCLOSPORINEVERSUS LOW-DOSE CYCLOSPORINE AND LOW-DOSE METHOTREXATE
Authors: ZIKOS P VANLINT MT FRASSONI F LAMPARELLI T GUALANDI F OCCHINI D MORDINI N BERISSO G BREGANTE S DESTEFANO F SORACCO M VITALE V BACIGALUPO A
Citation: P. Zikos et al., LOW TRANSPLANT MORTALITY IN ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOID-LEUKEMIA - A RANDOMIZED STUDY OF LOW-DOSE CYCLOSPORINEVERSUS LOW-DOSE CYCLOSPORINE AND LOW-DOSE METHOTREXATE, Blood, 91(9), 1998, pp. 3503-3508
BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA (CML) FROM UNRELATED AND SIBLING DONORS - SINGLE-CENTER EXPERIENCE
Authors: LAMPARELLI T VANLINT MT GUALANDI F OCCHINI D BARBANTI M SACCHI N FICAI G GHINATTI C FERRARA GB DELFINO L POZZI S MORABITO A ZIKOS P VITALE V CORVO R FRASSONI F BACIGALUPO A
Citation: T. Lamparelli et al., BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA (CML) FROM UNRELATED AND SIBLING DONORS - SINGLE-CENTER EXPERIENCE, Bone marrow transplantation, 20(12), 1997, pp. 1057-1062
DONOR LYMPHOCYTE INFUSIONS (DLI) IN PATIENTS WITH CHRONIC MYELOID-LEUKEMIA FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: BACIGALUPO A SORACCO M VASSALLO F ABATE M VANLINT MT GUALANDI F LAMPARELLI T OCCHINI D MORDINI N BREGANTE S FIGARI O BENVENUTO F SESSAREGO M FUGAZZA G CARLIER P VALBONESI M
Citation: A. Bacigalupo et al., DONOR LYMPHOCYTE INFUSIONS (DLI) IN PATIENTS WITH CHRONIC MYELOID-LEUKEMIA FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 19(9), 1997, pp. 927-932
TRANSPLANTATION OF HLA-MISMATCHED CD34(- SEVERE IMMUNODEFICIENCY AND RELATED COMPLICATIONS() SELECTED CELLS IN PATIENTS WITH ADVANCED MALIGNANCIES )
Authors: BACIGALUPO A MORDINI N PITTO A PIAGGIO G PODESTA M BENVENUTO F VANLINT MT VALBONESI M LERCARI G CARLIER P LAMPARELLI T GUALANDI F OCCHINI D BREGANTE S FIGARI O SORACCO M VASSALLO F DESTEFANO G
Citation: A. Bacigalupo et al., TRANSPLANTATION OF HLA-MISMATCHED CD34(- SEVERE IMMUNODEFICIENCY AND RELATED COMPLICATIONS() SELECTED CELLS IN PATIENTS WITH ADVANCED MALIGNANCIES ), British Journal of Haematology, 98(3), 1997, pp. 760-766
CYTOGENETIC ABNORMALITIES IN PATIENTS WITH SEVERE APLASTIC-ANEMIA
Authors: MIKHAILOVA N SESSAREGO M FUGAZZA G CAIMO A DEFILIPPI S VANLINT MT BREGANTE S VALERIANI A MORDINI N LAMPARELLI T GUALANDI F OCCHINI D BACIGALUPO A
Citation: N. Mikhailova et al., CYTOGENETIC ABNORMALITIES IN PATIENTS WITH SEVERE APLASTIC-ANEMIA, Haematologica, 81(5), 1996, pp. 418-422
COMBINED FOSCARNET-GANCICLOVIR TREATMENT FOR CYTOMEGALOVIRUS INFECTIONS AFTER ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTATION (HSCT)
Authors: BACIGALUPO A BREGANTE S TEDONE E ISAZA A VANLINT MT MORO F TRESPI G OCCHINI D GUALANDI F LAMPARELLI T MARMONT AM
Citation: A. Bacigalupo et al., COMBINED FOSCARNET-GANCICLOVIR TREATMENT FOR CYTOMEGALOVIRUS INFECTIONS AFTER ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTATION (HSCT), Bone marrow transplantation, 18, 1996, pp. 110-114
UNRELATED DONOR MARROW TRANSPLANTATION - INITIAL EXPERIENCE OF THE ITALIAN BONE-MARROW TRANSPLANT GROUP (GITMO)
Authors: DINI G LANINO E LAMPARELLI T BARBANTI M SACCHI N CARCASSI C LOCATELLI F PORTA F ROSTI G ALESSANDRINO EP AVERSA F MARENCO P GUIDI S UDERZO C AMOROSO A DIBARTOLOMEO P GARBARINO L LANASA G ROSSETTI F MINIERO R SOLIGO D MANFREDINI L BACIGALUPO A
Citation: G. Dini et al., UNRELATED DONOR MARROW TRANSPLANTATION - INITIAL EXPERIENCE OF THE ITALIAN BONE-MARROW TRANSPLANT GROUP (GITMO), Bone marrow transplantation, 17(1), 1996, pp. 55-62
EFFECT OF HLA CLASS-I MISMATCHES IN ADULT UNRELATED BONE-MARROW TRANSPLANTATION
Authors: FERRARA GB BINI D DELFINO L MORABITO A PERA C POZZI S BOTTERO F LAMPARELLI T BACIGALUPO A
Citation: Gb. Ferrara et al., EFFECT OF HLA CLASS-I MISMATCHES IN ADULT UNRELATED BONE-MARROW TRANSPLANTATION, Human immunology, 49, 1996, pp. 73-73
INDIVIDUATION OF A MICROSATELLITE MARKER ASSOCIATED TO A GVHD GENE INTHE LONG ARM OF CHROMOSOME-22
Authors: FERRARA GB BINI D POZZI S BOTTERO F LAMPARELLI T BACIGALUPO A
Citation: Gb. Ferrara et al., INDIVIDUATION OF A MICROSATELLITE MARKER ASSOCIATED TO A GVHD GENE INTHE LONG ARM OF CHROMOSOME-22, Human immunology, 49, 1996, pp. 112-112
COMBINED FOSCARNET-GANCICLOVIR TREATMENT FOR CYTOMEGALOVIRUS INFECTIONS AFTER ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTATION
Authors: BACIGALUPO A BREGANTE S TEDONE E ISAZA A VANLINT MT TRESPI G OCCHINI D GUALANDI F LAMPARELLI T MARMONT AM
Citation: A. Bacigalupo et al., COMBINED FOSCARNET-GANCICLOVIR TREATMENT FOR CYTOMEGALOVIRUS INFECTIONS AFTER ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTATION, Transplantation, 62(3), 1996, pp. 376-380
THIOTEPA CYCLOPHOSPHAMIDE FOLLOWED BY GRANULOCYTE-COLONY-STIMULATING FACTOR MOBILIZED ALLOGENEIC PERIPHERAL-BLOOD CELLS IN ADULTS WITH ADVANCED LEUKEMIA
Authors: BACIGALUPO A VANLINT MT VALBONESI M LERCARI G CARLIER P LAMPARELLI T GUALANDI F OCCHINI D BREGANTE S VALERIANI A PIAGGIO G PITTO A BENVENUTO F FIGARI O DESTEFANO G CAIMO A SESSAREGO M
Citation: A. Bacigalupo et al., THIOTEPA CYCLOPHOSPHAMIDE FOLLOWED BY GRANULOCYTE-COLONY-STIMULATING FACTOR MOBILIZED ALLOGENEIC PERIPHERAL-BLOOD CELLS IN ADULTS WITH ADVANCED LEUKEMIA, Blood, 88(1), 1996, pp. 353-357
Risultati: 1-25 | 26-37